AstraZeneca Pharma Approves ₹36 Dividend; Shares Fall 0.78%

Mumbai August, 11: AstraZeneca Pharma India Limited has approved a dividend of ₹36 per equity share at its 47th Annual General Meeting held on Monday, August 10, 2026.

According to the company’s exchange disclosure, the dividend declaration was one of the key business items approved at the AGM. The meeting was conducted through video conferencing and other audio-visual means and commenced at 3:18 PM after the required quorum was established.

The dividend resolution was approved alongside the adoption of the company’s financial statements for the financial year ended March 31, 2026.

The ₹36 per share payout represents the shareholder distribution approved for the financial year. The available filing does not state the aggregate dividend amount, and this report is focused solely on the dividend declaration.

Stock Market Snapshot

AstraZeneca Pharma shares opened lower on Tuesday as the market reacted to the latest corporate disclosure.

As of 9:27 AM IST on August 11, 2026, the AstraZeneca Pharma share price stood at ₹8,026.50, down ₹63.50, or 0.78%, from the previous close of ₹8,090.

The stock opened at ₹7,966 and moved up to an early high of ₹8,050. Its VWAP stood at ₹8,017.41 at the time of the latest available market data.

The shares were therefore trading close to the ₹8,000 mark during the opening phase, despite the company having approved the ₹36 dividend at its AGM.

As the market was still open at the time of the quoted price, the stock’s movement could change during the session.

Company Background

AstraZeneca Pharma India is the Indian listed pharmaceutical business of AstraZeneca and operates across several therapeutic areas, including oncology, cardiovascular, renal and metabolic diseases and respiratory care.

The company provides medicines and healthcare solutions to the Indian market and is listed on both the BSE and NSE.

The latest AGM disclosure formally records the approval of the ₹36 per equity share dividend for shareholders, making the payout one of the key corporate actions arising from the company’s annual general meeting.

Conclusion

AstraZeneca Pharma India has approved a ₹36 per equity share dividend at its 47th AGM held on August 10, 2026.

The dividend was part of the resolutions considered by shareholders at the meeting and was approved along with the adoption of the company’s financial statements for the year ended March 31, 2026.

On the stock market, the AstraZeneca Pharma share price was ₹8,026.50 as of 9:27 AM IST on August 11, 2026, down 0.78% from the previous close.

Source:

• https://nsearchives.nseindia.com/corporate/ASTRAZEN_10082026233540_Proceedings_of_AGM_2026.pdf
• https://www.nseindia.com/get-quote/equity/ASTRAZEN/AstraZeneca-Pharma-India-Limited